Fujifilm announced an additional $1.2 billion investment this month to expand its end-to-end bio-manufacturing facility in Holly Springs, North Carolina. The expansion brings Fujifilm’s total investment in its North Carolina facility to over $3.2 billion and is projected to create 680 new jobs by 2031. The fresh investment also makes it the largest facility of its kind in North America.
“This investment is an important step to further accelerate the growth of our biopharmaceutical CDMO (contract development and manufacturing organization) business,” said Fujifilm Corp. President and CEO Teiichi Goto.
“Fujifilm is committed to advancing a healthier society, and we are proud that our people, and this site in Holly Springs will play a vital role in supporting our partners in producing critical therapies to serve the needs of patients,” Goto added.
According to Fujifilm, the investment will also support its initiatives that contribute to net-zero operations.
Meanwhile, Economic Development Partnership of North Carolina CEO Christopher Chung expressed support for the project.
“North Carolina is known worldwide as a biotechnology hub thanks to the continued investment from companies like Fujifilm Diosynth. Our robust infrastructure, top-notch engineering talent in the state, and partnerships with entities like NC State University and the North Carolina Biotechnology Center, provide support for innovative companies like FUJIFILM to continue to grow.”
